Sahil Parikh, MD, director of endovascular services at Columbia University Irving Medical Center, said treating these patients can be quite challenging. 

Alexandra Bastiany, MD, made history when she became Canada’s first Black female interventional cardiologist in 2020. Now, that achievement is being recognized in a surprising way.

Reventics, a revenue cycle management company and a business associate of Regional One Health, detected a cyber-intruder who accessed the company’s servers in December 2022.

The announcement comes as more Alzheimer’s drugs are being evaluated with hopes that some new treatments could be breakthroughs.

“It's all about risks and benefits," one researcher said. "Starting transitioning is a big part of a person's life and helping them feel more themselves, but hormone replacement therapy also has a lot of side effects—it's not a risk-free endeavor."

Mammography screening trends had remained flat, but they fell across all age groups after the USPSTF issued new guidelines in 2009.

New research suggests that the tissue environment where microcalcifications of the breast are formed could hold clues into how breast cancer progresses.

The device, which gained FDA approval in 2021, was part of a voluntary recall in 2022 due to stability concerns. Medtronic worked with the FDA to address the issue, and the Harmony TPV is once again available throughout the United States. 

The project may inform theories of human neurodevelopment as dynamically as it advances computer and data science.

Humana plans to pull out of the commercial insurance space over the next 18 to 24 months.